ChromaDex

ChromaDex is a global bioscience company focused on the discovery, development, and commercialization of novel ingredients and proprietary technologies aimed at improving the way people age. Founded in 1999, ChromaDex initially specialized in the development and marketing of phytochemical and botanical reference standards and other research-grade materials. Over the years, the company has expanded its focus to include the development of Nicotinamide Riboside (NR), a form of vitamin B3, and other NAD+ precursors aimed at promoting healthy aging.

History

ChromaDex was established in 1999 with the primary goal of providing comprehensive services and products for the natural products industry. The company's early focus was on supplying high-quality reference standards, which are critical for the accurate identification and quantification of dietary supplements and natural products. As the company grew, it shifted its focus towards the science of aging and the potential of molecules like Nicotinamide Riboside to improve healthspan.

Products and Services

The company's flagship product is Tru Niagen, a supplement containing its patented form of Nicotinamide Riboside chloride branded as NIAGEN. Tru Niagen aims to increase NAD+ levels in the body, supporting cellular health and resilience. ChromaDex also continues to offer a range of analytical services, reference materials, and products for research and development in the nutraceutical, pharmaceutical, and cosmetic industries.

Research and Development

ChromaDex places a strong emphasis on scientific research and has invested significantly in clinical trials to explore the benefits of NR and other NAD+ precursors. The company collaborates with universities and research institutions worldwide to study the effects of its products on aging, metabolic health, and other areas of wellness.

Corporate Affairs

ChromaDex operates globally, with its headquarters located in Los Angeles, California. The company's business model encompasses direct-to-consumer sales, as well as partnerships with other businesses for the distribution of its products and services.

Regulatory Compliance

As a supplier of dietary supplements and a participant in the health and wellness industry, ChromaDex adheres to regulatory standards set by agencies such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA). The company is committed to ensuring the safety, quality, and efficacy of its products.

Challenges and Controversies

Like many companies in the dietary supplement industry, ChromaDex has faced challenges and controversies, particularly regarding the scientific evidence supporting the health benefits of its products and the regulatory landscape of dietary supplements. However, the company continues to support its claims with ongoing research and clinical trials.

Future Directions

ChromaDex remains dedicated to advancing the science of aging and exploring new ways to promote healthy aging through nutritional supplementation. The company is actively researching additional compounds that could complement Nicotinamide Riboside in supporting cellular health and longevity.

This article is a stub related to pharmacology. You can help WikiMD by expanding it!